IMPURE (Injection Moulding Repurposing for Medical Supplies enabled by Additive Manufacturing)
Program: H2020
Reference: 101016262
RESOLUTION Date: 03/11/2020
Date of execution: 01/12/2020-31/05/2022
The imPURE (Injection Moulding Repurposing for Medical Supplies Enabled by Additive Manufacturing) project aims to reuse existing injection molding lines to, by integrating modular molds with interchangeable cavity plates, meet urgent needs for vital medical supplies and equipment.
In a highly interconnected world with high mobility of people, today’s society faces a major challenge to harmonize risk mitigation measures against emerging biological hazards. Any delay in imposing risk mitigation measures is decisive and can make the difference between suffering a local outbreak of a disease with few cases, or its evolution into a pandemic with countless sick and deceased citizens, as coronavirus disease 2019 (COVID-19) has been responsible for demonstrating. Therefore, it is of utmost importance that appropriate and proportionate measures are immediately applied to each phase of the pandemic to interrupt human-to-human transmission chains, prevent further spread and reduce the intensity of the COVID-19 outbreak. Immediate activation of national emergency response mechanisms and pandemic preparedness plans, including non-pharmaceutical public health measures, are critical to delay transmission or decrease the peak of the outbreak to enable health systems to prepare for and cope with an increased influx of patients. However, high demand and/or low supply for certain medical items has led to unprecedented shortages and disruptions in the global medical supply chain. As a result, many large and small companies outside the traditional medical supply system are reconfiguring their procedures for the mass production of critical medical consumables.
In this context, the imPURE project concept is based on the development of modular molds, with inserts manufactured by additive manufacturing, for the reuse of injection molding lines belonging to other sectors, and dedicate them to the manufacture of medical supplies.
ITAINNOVA participates in the project by performing numerical modeling work for the optimization of mold and process design, along with digital twin technologies and process monitoring in the cloud to speed up the response and reduce the personnel required in the plant in person.
NATIONAL TECHNICAL UNIVERSITY OF ATHENS (NTUA),
UNIVERSITY OF STRATHCLYDE (UOS)
PASCOE ENGINEERING LTD (PASCOE),
CONIFY IKE (CONI)
NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU (NTNU),
TECHNOLOGICAL INSTITUTE OF ARAGON (ITAINNOVA)
INSTITUT DE RECHERCHE TECHNOLOGIQUE JULES VERNE (IRT),
BIOG3D NEES TEXNOLOGIES 3D DESPOINA BRASINIKA IKE (BioG3D),
WARRANT HUB SPA (WH),
Producta (PROD),
INNOVATION IN RESEARCH & ENGINEERING SOLUTIONS (IRES),
StilGommas.r.l. (STIL),
ANG ALBERTO NICOLINI GROUP SRL (DBM),
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON (NKUA)
ELVEZ, PROIZVODNJA KABELSKE KONFEKCIJE IN PREDELAVA PLASTICNIH MAS DOO (ELVEZ)
SIDAM SRL (SIDAM),
NEW INFRARED TECHNOLOGIES SL (NIT),
IUNGO SPA (IUNGO),
INTEGRATED ENVIRONMENTAL SOLUTIONS LIMITED (IES),
TOTAL PROJECT BUDGET: 7,286,762.50 €.
TOTAL BUDGET ITAINNOVA: 368.125,00 €.
TOTAL PROJECT GRANT: 5,783,800.00 €.
TOTAL FINANCING ITANNOVA: 368.125,00 €.
This action is co-financed by the IMPURE project whose reference is 101016262 and is marked in the H2020 program, 100% financed by the European Union.
